Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Endophytic fungi are microorganisms that exist almost ubiquitously inside the various tissues of living plants where they act as an important reservoir of diverse bioactive compounds. Recently, endophytic fungi have drawn tremendous attention from researchers; their isolation, culture, purification, and characterization have revealed the presence of around 200 important and diverse compounds including anticancer agents, antibiotics, antifungals, antivirals, immunosuppressants, and antimycotics. Many of these anticancer compounds, such as paclitaxel, camptothecin, vinblastine, vincristine, podophyllotoxin, and their derivatives, are currently being used clinically for the treatment of various cancers (e.g., ovarian, breast, prostate, lung cancers, and leukemias). By increasing the yield of specific compounds with genetic engineering and other biotechnologies, endophytic fungi could be a promising, prolific source of anticancer drugs. In the future, compounds derived from endophytic fungi could increase treatment availability and cost effectiveness. This comprehensive review includes the putative anticancer compounds from plant-derived endophytic fungi discovered from 1990 to 2020 with their source endophytic fungi and host plants as well as their antitumor activity against various cell lines.

Details

Title
Putative Anticancer Compounds from Plant-Derived Endophytic Fungi: A Review
Author
Hridoy, Md 1   VIAFID ORCID Logo  ; Md Zobayer Hossain Gorapi 2 ; Noor, Sadia 3 ; Nargis Sultana Chowdhury 4 ; Rahman, Md Mustafizur 5   VIAFID ORCID Logo  ; Muscari, Isabella 6 ; Masia, Francesco 6 ; Adorisio, Sabrina 7 ; Delfino, Domenico V 7   VIAFID ORCID Logo  ; Md Abdul Mazid 8   VIAFID ORCID Logo 

 Department of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh; [email protected]; Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA 
 Department of Pharmacy, University of Asia Pacific, Dhaka 1215, Bangladesh; [email protected] (M.Z.H.G.); [email protected] (S.N.) 
 Department of Pharmacy, University of Asia Pacific, Dhaka 1215, Bangladesh; [email protected] (M.Z.H.G.); [email protected] (S.N.); Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh 
 Department of Pharmacy, Manarat International University, Dhaka 1343, Bangladesh; [email protected] 
 Pharmacy Discipline, Khulna University, Khulna 9208, Bangladesh; [email protected] 
 Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy; [email protected] (I.M.); [email protected] (F.M.) 
 Department of Medicine and Surgery, Foligno Nursing School and Section of Pharmacology, University of Perugia, Piazzale Severi, S. Andrea delle Fratte, 06129 Perugia, Italy; [email protected] 
 Department of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh; [email protected]; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh 
First page
296
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
14203049
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2618239506
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.